These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 9204238)
41. [Prenatal screening for major fetal defects by using of maternal serum markers]. Bao P; Wu Y; Gu Q Zhonghua Fu Chan Ke Za Zhi; 1997 Nov; 32(11):649-51. PubMed ID: 9639762 [TBL] [Abstract][Full Text] [Related]
42. Intrauterine fetal diagnosis for hematologic and other congenital disorders. Kramer K; Cohen HJ Clin Lab Med; 1999 Mar; 19(1):239-53, vii-viii. PubMed ID: 10403082 [TBL] [Abstract][Full Text] [Related]
43. [New frontiers in noninvasive, prenatal screening and diagnosis: fetal DNA circulating in maternal blood]. Montagnana M; Lippi G; Guidi GC Minerva Ginecol; 2007 Jun; 59(3):331-41. PubMed ID: 17576408 [TBL] [Abstract][Full Text] [Related]
45. [Fetal trisomy 21 risk evaluation by measurement of maternal serum markers]. Dhondt JL Ann Biol Clin (Paris); 1998; 56(4):471-5. PubMed ID: 9754284 [No Abstract] [Full Text] [Related]
46. The use of cell-free fetal nucleic acids in maternal blood for non-invasive prenatal diagnosis. Wright CF; Burton H Hum Reprod Update; 2009; 15(1):139-51. PubMed ID: 18945714 [TBL] [Abstract][Full Text] [Related]
47. [Prenatal screening for Down's syndrome]. Qin Q; Christiansen M; Norgaard-Pedersen B Zhonghua Fu Chan Ke Za Zhi; 1997 Nov; 32(11):694-7. PubMed ID: 9639772 [No Abstract] [Full Text] [Related]
48. [AFP, uE3, beta-hCG levels applied for prenatal diagnosis of Down's syndrome]. Liao S; Wang Y; Ye G Zhonghua Fu Chan Ke Za Zhi; 1997 Nov; 32(11):655-8. PubMed ID: 9639764 [TBL] [Abstract][Full Text] [Related]
49. Prenatal diagnosis using fetal cells enriched from maternal blood. Holzgreve W; Di Naro E; Garvin AM; Troeger C; Hahn S Croat Med J; 1998 Jun; 39(2):115-20. PubMed ID: 9575265 [TBL] [Abstract][Full Text] [Related]
50. [The value and drawbacks of evaluation of the risk of fetal trisomy 21]. Taieb J; Benattar C; Audibert F; Frydman R; Lindenbaum A Contracept Fertil Sex; 1997 Apr; 25(4):269-76. PubMed ID: 9229515 [No Abstract] [Full Text] [Related]
51. [Cordocentesis for prenatal diagnosis of fetal diseases]. Xiang Y; Chang X; Sun N; Bian X; Wang F Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1996 Feb; 18(1):33-7. PubMed ID: 9208585 [TBL] [Abstract][Full Text] [Related]
53. Severe fetal cytomegalic inclusion disease after documented maternal reactivation of cytomegalovirus infection during pregnancy. Rousseau T; Douvier S; Reynaud I; Laurent N; Bour JB; Durand C; Spagnolo G; Sagot P Prenat Diagn; 2000 Apr; 20(4):333-6. PubMed ID: 10740207 [TBL] [Abstract][Full Text] [Related]
54. Prenatal testing for aneuploidy in New Zealand: time for action. Stone P N Z Med J; 2005 Jun; 118(1217):U1545. PubMed ID: 15980916 [No Abstract] [Full Text] [Related]
55. [Progress in the technique of sorting fetal cells from maternal peripheral blood]. Zhou Z Zhonghua Fu Chan Ke Za Zhi; 1999 Jun; 34(6):373-5. PubMed ID: 11360618 [No Abstract] [Full Text] [Related]